The ACUSON X300 works to provide compact, portable color Doppler solutions for adult, pediatric, OR, EP and interventional cardiology applications.

The system features a compact design and a console that reportedly helps to reduce arm and hand movement, designed to provide small, lightweight transducers.

January 2008

W. L. Gore & Associates (Gore) announced that the FDA granted approval for the use of GORE HELEX Septal Occluder with a modified catheter delivery system indicated for the transcatheter closure of atrial septal defect (ASD), providing a percutaneous ASD closure solution for very young patients.

Siemens Medical Solutions received FDA 510(k) clearance for a 1.5T magnetic resonance imaging (MRI) system that is reportedly more affordable, allowing providers to upgrade from low-field MRI systems or to add an MRI system for the first time.
The cost of the new 1.5T MAGNETOM Essenza can reportedly be as much as $500,000 less than other 1.5T systems, making it possible for small hospitals and diagnostic imaging centers to offer a new range of imaging services. The magnet is lightweight (approximately 3.5 tons) and has an ultra-short bore length of 145 centimeters.

Toshiba America Medical Systems Inc. recently introduced its Infinix VF-i/SP X-ray system, a universal cardiovascular system designed to accommodate diagnostic and interventional procedures.

Based on the Infinix-i series platform, the new floor-mounted, single plane system features a multi-axis positioner with versatile movement for better patient access and anatomical coverage, including head-to-toe, finger tip-to-finger tip coverage. A high-resolution 12-by-16-inch flat panel detector also provides uniform, distortion-free images.

February 19, 2008 – Clinicians implanted the BioMatrix drug-eluting stent system into the first European patients in a live broadcast during the Joint Interventional Meeting (JIM), held in Rome, Italy, from February 13-15.

The BioMatrix drug-eluting stent system, by Biosensors International Group Ltd., combines a biodegradable PLA and the company’s proprietary limus drug, Biolimus A9.

February 19, 2008 – The first CE certified Nobori Drug-Eluting Coronary Stent System was successfully implanted in Europe, as Terumo Corp. is poised to expand the product from spring 2008 to more than 20 countries in Europe, Asia, New Zealand and Africa.

February 19, 2008 - Boston Scientific Corp. closed the sale of its Fluid Management and Venous Access businesses to Avista Capital Partners for $425 million in cash, completing its divestiture of five non-strategic businesses.

The sale follows the definitive agreement announced on Dec. 13, 2007. The Company expects to record an after-tax gain of approximately $120 million during the first quarter of 2008 in connection with the transaction.

February 19, 2008 – A novel, fully bioabsorbable salicylate-based stent offers the potential to reduce adverse events associated with current drug-eluting stents (DES) and could be very beneficial to patients with coronary heart disease, according to a presentation at the Cardiovascular Revascularization Therapies 2008 (CRT) symposium.

February 19, 2008 - Among patients with acute myocardial infarction (AMI), prior statin therapy is associated with better perfusion after primary angioplasty of the infarct-related artery, according to a report in the January 15 issue of the American Journal of Cardiology.

February 19, 2008 – The American College of Cardiology (ACC) urges the medical community to oppose cuts to medical imaging services and support policies that foster imaging appropriateness and quality, after receiving news of a congressional intervention to delay the cuts for six months and stop the 10 percent cut to Medicare physician payment from taking place on Jan. 1.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now